Liliumtx
1 known investors
Lilium develops genetic medicines that selectively target pathogenic T cells in autoimmune diseases using engineered delivery vehicles for precision immune reprogramming. The company focuses on treating T-cell mediated autoimmune diseases and oncology indications that currently lack effective treatments.
BiotechDeep TechDigital Health